Skip to main content
. 2020 Dec 17;8:100307. doi: 10.1016/j.ejro.2020.100307

Table 2.

Performance of ABB-MRI protocols in screening settings to women who had undergone breast MRI for varied indications.

Study Lesions Cancers/ Subjects Reference Readers Exper. (years) Sens. Spec. PPV PNV Agree.
Mango et al. [45] 100 100/100 Biopsy 4 518 96 92.9
Heacock et al. [47] 107 107/107 Biopsy 3 26 96.3100




98.1100




98.1100
Chen et al. [48] 41 16/478 Biopsy/ follow-up 2 10 93.8 88.3 21.7 99.8
Chen et al. [49] 67 14/356 Biopsy/ follow-up 3 1015 92.9
86.5
22
99.7

100 95 45.2 100
Machida et al. [64] 53 31/88 Biopsy/ follow-up 2 613 90.3 87.55 61.95 97.7 0.56
Oldrini et al. [38] 106 58/70 Biopsy 2 56 93.95
25
60.25
77.5

93.1
60.4
74
87.9
0.8
89.7
60.4
73.25
82.85

93.1 77.05 83.25 90.2 0.87
Petrillo et al. [51] 295 207/508 Biopsy/ follow-up 2 20 99.5 75.4 73.5 99.6 0.99
Oldrini et al. [41] 26 26/90 Biopsy/ follow-up 2 0.56 100 93.3
Yamada et al. [54] 89 89/87 Biopsy 2 815 89.995.5
97.694.1


0.45
95.598.9 90.694.1 0.56
Milon et al. [27] 179 110/120 Biopsy 2 26 92
27
63
72
0.8
95 45 70 87 0.89